Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Inhibition of retinoic acid signaling in proximal tubular epithelial cells protects against acute kidney injury
Min Yang, … , Alan J. Davidson, Mark de Caestecker
Min Yang, … , Alan J. Davidson, Mark de Caestecker
Published September 12, 2023
Citation Information: JCI Insight. 2023;8(20):e173144. https://doi.org/10.1172/jci.insight.173144.
View: Text | PDF
Research Article Nephrology

Inhibition of retinoic acid signaling in proximal tubular epithelial cells protects against acute kidney injury

  • Text
  • PDF
Abstract

Retinoic acid receptor (RAR) signaling is essential for mammalian kidney development but, in the adult kidney, is restricted to occasional collecting duct epithelial cells. We now show that there is widespread reactivation of RAR signaling in proximal tubular epithelial cells (PTECs) in human sepsis-associated acute kidney injury (AKI) and in mouse models of AKI. Genetic inhibition of RAR signaling in PTECs protected against experimental AKI but was unexpectedly associated with increased expression of the PTEC injury marker Kim1. However, the protective effects of inhibiting PTEC RAR signaling were associated with increased Kim1-dependent apoptotic cell clearance, or efferocytosis, and this was associated with dedifferentiation, proliferation, and metabolic reprogramming of PTECs. These data demonstrate the functional role that reactivation of RAR signaling plays in regulating PTEC differentiation and function in human and experimental AKI.

Authors

Min Yang, Lauren N. Lopez, Maya Brewer, Rachel Delgado, Anna Menshikh, Kelly Clouthier, Yuantee Zhu, Thitinee Vanichapol, Haichun Yang, Raymond C. Harris, Leslie Gewin, Craig R. Brooks, Alan J. Davidson, Mark de Caestecker

×

Figure 8

Increased efferocytosis in PTEC DN RAR mice after AKI.

Options: View larger image (or click on image) Download as PowerPoint
Increased efferocytosis in PTEC DN RAR mice after AKI.
(A–E) Apoptosis i...
(A–E) Apoptosis in PTEC DN RAR mice 3 days after Rhabdo-AKI. (A) The percentage of TUNEL+LTL+ cells in the cortex and OSOM. (B) TUNEL and LTL staining in the OSOM. (C) Percentage of MLKL staining. (D) MLKL with LTL and Kim1 staining in the OSOM. (E–G) Kim1 expression and endocytic activity in cultured PTECs. (E) Kim1 fluorescence intensity. (F) PTECs uptake of fluorescently conjugated oxidized LDL (Ox-LDL). Fluorescence intensity and numbers of PTECs taking up Ox-LDL. (G) Kim1 staining and Ox-LDL uptake. (H and I) Lysosomal clearance of apoptotic cells in PTEC DN RAR mice. (H) PTEC DN RAR mice after bilateral IRI-AKI pretreated with bafilomycin A1. Kidneys harvested at 24 hours. The percentage of TUNEL+LTL+ cells in the OSOM. (I) TUNEL and LTL staining. Scale bars: 100 mM (B, D, E, and J), 20 mM (H). A, C, E, and F used t tests, with P values comparing PEPCK Cre+ and Cre– mice. H used 1-way ANOVA, with P < 0.05 considered significant; q values are shown for between-group comparisons corrected for repeated testing.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts